Increased prevalence of regurgitant valvular heart disease in acromegaly

被引:111
作者
Pereira, AM
van Thiel, SW
Lindner, JR
Roelfsema, F
van der Wall, EE
Morreau, H
Smit, JWA
Romijn, JA
Bax, JJ
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[4] Univ Virginia, Div Cardiovasc, Charlottesville, VA 22908 USA
关键词
D O I
10.1210/jc.2003-030849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac involvement is common in acromegaly, but the prevalence of valvular abnormalities in patients with acromegaly has not been documented and is the topic of this study. In a prospective study design, 40 consecutive patients with acromegaly and 120 control subjects (matched for age, sex, hypertension, and left ventricular systolic function) were studied. All patients and controls were evaluated using conventional two-dimensional and Doppler echocardiography. Significant valve disease was more prevalent in acromegalics compared with controls (22% vs. 6.7%, respectively; P = 0.005). Aortic valve regurgitation (greater than or equal totrace severity) was present in 30% of patients vs. 7% of controls (P < 0.001), and mitral regurgitation (>= moderate severity) was absent in controls but present in 5% of acromegalics (P = 0.014 vs. controls). Binary logistic regression analysis showed a significant impact only for disease duration on valvular disease, with an odds ratio of 1.19 (95% confidence interval, 1.028-1.376; P = 0.019). Acromegaly is associated with an increased prevalence of regurgitant valvular heart disease. This is dependent on the duration of exposure to increased GH concentrations, with a 19% increase in odds per year. This increased prevalence of occult valvular disease indicates that these patients require appropriate follow-up care and monitoring, especially patients with inadequate control of GH overproduction.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 22 条
[1]   Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months [J].
Burger, AJ ;
Sherman, HB ;
Charlamb, MJ ;
Kim, J ;
Asinas, LA ;
Flickner, SR ;
Blackburn, GL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1153-1158
[2]   Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study [J].
Colao, A ;
Cuocolo, A ;
Marzullo, P ;
Nicolai, E ;
Ferone, D ;
Della Morte, AM ;
Petretta, M ;
Salvatore, M ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1518-1523
[3]   High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study [J].
Colao, A ;
Spinelli, L ;
Marzullo, P ;
Pivonello, R ;
Petretta, M ;
Di Somma, C ;
Vitale, G ;
Bonaduce, D ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3196-3201
[4]   Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure? [J].
Creemers, EEJM ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP .
CIRCULATION RESEARCH, 2001, 89 (03) :201-210
[5]   Matrix metalloproteinase expression in nonrheumatic aortic stenosis [J].
Edep, ME ;
Shirani, J ;
Wolf, P ;
Brown, DL .
CARDIOVASCULAR PATHOLOGY, 2000, 9 (05) :281-286
[6]  
Feelders RA, 2002, 84 ANN M END SOC SAN, P76
[7]   COLOR DOPPLER ASSESSMENT OF MITRAL REGURGITATION WITH ORTHOGONAL PLANES [J].
HELMCKE, F ;
NANDA, NC ;
HSIUNG, MC ;
SOTO, B ;
ADEY, CK ;
GOYAL, RG ;
GATEWOOD, RP .
CIRCULATION, 1987, 75 (01) :175-183
[8]   Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: The Strong Heart Study [J].
Ilercil, A ;
O'Grady, MJ ;
Roman, MJ ;
Paranicas, M ;
Lee, ET ;
Welty, TK ;
Fabsitz, RR ;
Howard, BV ;
Devereux, RB .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2001, 14 (06) :601-611
[9]   A SIMPLIFIED NORMALIZED EJECTION PHASE INDEX MEASURED BY DOPPLER ECHOCARDIOGRAPHY FOR THE ASSESSMENT OF LEFT-VENTRICULAR PERFORMANCE [J].
ISAAZ, K ;
ETHEVENOT, G ;
ADMANT, P ;
BREMBILLA, B ;
PERNOT, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (18) :1246-1251
[10]   MITRAL-VALVE PROLAPSE - A CONSISTENT MANIFESTATION OF TYPE-IV EHLERS-DANLOS SYNDROME - THE PATHOGENETIC ROLE OF THE ABNORMAL PRODUCTION OF TYPE-III COLLAGEN [J].
JAFFE, AS ;
GELTMAN, EM ;
RODEY, GE ;
UITTO, J .
CIRCULATION, 1981, 64 (01) :121-125